BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
Copyright: ©Author(s) 2026.
World J Gastrointest Surg. Jul 27, 2026; 18(7): 120222
Published online Jul 27, 2026. doi: 10.4240/wjgs.v18.i7.120222
Table 1 Baseline demographic and clinical characteristics of patients before and after propensity score matching, n (%)/mean ± SD
CharacteristicPre-matched cohort
Post-matched cohort (n = 125 pairs)
Watson-FTS (n = 165)
Routine care (n = 147)
Test statistic
P value
SMD
Watson-FTS (n = 125)
Routine care (n = 125)
Test statistic
P value
SMD
Demographics
Age, years62.1 ± 10.864.5 ± 11.41.910.0570.2263.2 ± 10.563.5 ± 10.90.220.8250.03
Male gender96 (58.2)85 (57.8)0.010.9480.0172 (57.6)71 (56.8)0.020.8980.02
BMI, kg/m223.6 ± 3.423.1 ± 3.71.240.2160.1423.4 ± 3.223.3 ± 3.50.240.8140.03
Education (> high school)91 (55.2)59 (40.1)6.990.0080.3158 (46.4)60 (48.0)0.060.7990.03
Clinical status
ASA class III45 (27.3)38 (25.9)0.080.7760.0334 (27.2)33 (26.4)0.020.8870.02
NRS 2002 score2.6 ± 0.92.5 ± 1.10.880.380.12.5 ± 0.82.5 ± 0.9010
CCI score2.4 ± 1.52.6 ± 1.71.10.2720.122.5 ± 1.42.5 ± 1.5010
Smoking (current/former)64 (38.8)61 (41.5)0.240.6240.0649 (39.2)51 (40.8)0.070.7960.03
Neoadjuvant therapy35 (21.2)28 (19.0)0.240.6270.0525 (20.0)26 (20.8)0.020.8790.02
Psychological status
HADS-anxiety9.6 ± 3.17.9 ± 3.44.61< 0.0010.528.8 ± 2.98.9 ± 3.20.260.7950.03
HADS-depression8.9 ± 3.37.4 ± 3.24.07< 0.0010.468.2 ± 3.08.3 ± 2.80.270.7850.03
Surgical/oncological
Laparoscopic approach140 (84.8)101 (68.7)11.520.0010.495 (76.0)94 (75.2)0.020.8850.02
AJCC TNM stage III88 (53.3)76 (51.7)0.080.7750.0366 (52.8)65 (52.0)0.020.8980.02
Tumor location (rectum)102 (61.8)94 (63.9)0.150.6970.0478 (62.4)79 (63.2)0.020.8940.02
Permanent stoma65 (39.4)62 (42.2)0.250.6170.0650 (40.0)49 (39.2)0.020.8920.02
Preop albumin, g/L36.4 ± 4.536.9 ± 4.80.950.3430.1136.6 ± 4.236.7 ± 4.40.180.8540.02
Preop prealbumin, mg/L224 ± 51219 ± 550.830.4070.09221 ± 48223 ± 500.320.7480.04
Table 2 Comparison of primary outcomes in the matched cohort (n = 250), n (%)/mean ± SD
Outcome
Watson-FTS (n = 125)
Routine care (n = 125)
Unadjusted difference
Adjusted effect (95%CI)1
P value
First flatus time (hours)52.4 ± 10.868.1 ± 13.5-15.7β: -15.2 (-18.4 to -12.0)< 0.001
Overall complications19 (15.2)38 (30.4)-15.20aOR: 0.39 (0.21-0.72)0.003
Clavien-Dindo severity
    Grade I-II15 (12.0)30 (24.0)-12.00aOR: 0.43 (0.22-0.85)0.015
    Grade ≥ III4 (3.2)8 (6.4)-3.20aOR: 0.48 (0.14-1.66)0.246
Stoma-related events6 (4.8)16 (12.8)-8.00aOR: 0.34 (0.13-0.89)0.024
Table 3 Comparison of secondary outcomes in the matched cohort (n = 250), n (%)/mean ± SD
Outcome dimension
Watson-FTS (n = 125)
Routine care (n = 125)
Unadjusted difference
Adjusted effect (95%CI)1
P value
Physiological and functional
First ambulation time (hours)26.4 ± 6.238.9 ± 8.5-12.5 β: -12.1 (-13.8 to -10.4)< 0.001
Postoperative stay (days)2, median (IQR)7.0 (6.0, 8.0)9.0 (7.5, 11.0)-2.0 β: -1.8 (-2.3 to -1.3)< 0.001
Discharge KPS score84.5 ± 5.278.2 ± 6.1+6.3β: +5.9 (4.6-7.2)< 0.001
Humanistic process quality
Teach-back completion115 (92.0)81 (64.8)+27.2aOR: 5.82 (2.76-12.28)< 0.001
Individualized plan rate111 (88.8)65 (52.0)+36.8aOR: 7.14 (3.58-14.24)< 0.001
Self-efficacy milestone3102 (81.6)71 (56.8)+24.8aOR: 3.25 (1.84-5.74)< 0.001
Table 4 Generalized estimating equation model results for nutritional trajectories and protocol adherence (n = 250)
Model parameter
Prealbumin (mg/L) β (95%CI)
P value
FTS adherence (yes) OR (95%CI)
P value
Intercept222.8 (215.4-230.2)< 0.0010.82 (0.54-1.25)0.358
Group (Watson-FTS vs control)5.48 (2.12-8.84)0.0012.15 (1.42-3.26)< 0.001
Time (categorical reference: T1)
    T2 (day 3 for nutrition/adherence)17.6 (12.4-22.8)< 0.0012.56 (1.88-3.48)< 0.001
    T3 (day 7 for nutritional/day 5 for adherence)33.7 (28.5-38.9)< 0.0014.12 (2.95-5.76)< 0.001
Group × time interaction6.42 (4.15-8.69)< 0.0011.85 (1.18-2.90)0.008
Table 5 Multivariable regression analysis for predictors of postoperative recovery quality (n = 312)
Predictors
Model 1 early recovery success (flatus < 48 hours)
Model 2 functional status at discharge (KPS)
Adjusted OR (95%CI)
χ2
P value
Adjusted β (95%CI)
t value
P value
Watson-FTS intervention (ref: Routine)3.62 (2.18-6.01)24.15< 0.0016.24 (4.85-7.63)8.82< 0.001
Age (per year)0.97 (0.94-0.99)5.020.025-0.08 (-0.16 to 0.01)-2.140.033
BMI (kg/m2)1.04 (0.96-1.13)0.880.3480.12 (-0.15 to 0.39)0.860.391
Laparoscopic approach (ref: Open)2.45 (1.34-4.48)8.240.0042.85 (1.12-4.58)3.240.001
ASA class III (ref: I-II)0.78 (0.45-1.35)0.760.383-1.45 (-3.12 to 0.22)-1.710.088
TNM stage III (ref: I-II)0.82 (0.51-1.32)0.640.424-3.12 (-5.45 to 0.79)-2.630.009
Permanent stoma (ref: Temporary)0.88 (0.54-1.43)0.280.597-2.05 (-3.82 to 0.28)-2.280.023
Table 6 Subgroup analysis of the effect of Watson-fast track surgery on time to first flatus
Subgroup
n (Int/Con)
Adjusted beta (95%CI)
P value
P for interaction
Overall matched cohort125/125-15.2 (-18.4 to -12.0)< 0.001Reference
Age (years)0.784
    < 6574/76-15.4 (-18.9 to -11.9)< 0.001
    ≥ 6551/49-14.8 (-19.2 to -10.4)< 0.001
Surgical approach0.412
    Laparoscopic95/94-15.6 (-19.1 to -12.1)< 0.001
    Open30/31-13.9 (-18.2 to -9.6)< 0.001
Stoma type0.521
    Permanent50/49-16.2 (-19.8 to -12.6)< 0.001
    Temporary75/76-14.5 (-18.1 to -10.9)< 0.001
Table 7 Interrupted time-series analysis (segmented linear regression) evaluating the impact of the Watson-fast track surgery intervention on time to first flatus
Parameter
Estimate (hours)
SE
95%CI
t
P value
Baseline intercept (estimated time at Q1 2019)68.521.8464.91-72.1337.24< 0.001
Preintervention trend (change per quarter before Jan 2022)-0.150.14-0.42 to 0.12-1.070.312
Level change (intervention effect) (immediate drop at Q1 2022)-13.841.88-17.52 to -10.16-7.36< 0.001
Postintervention trend modification (change in slope after intervention)-0.050.1-0.24 to 0.14-0.50.62


Write to the Help Desk